Prolonged durability of extensive contiguous spinal metastasis stabilization in non-small cell lung cancer patients receiving targeted therapy: two case reports and a literature review
Issued Date
2022-06-01
Resource Type
ISSN
03000605
eISSN
14732300
Scopus ID
2-s2.0-85131710035
Pubmed ID
35681249
Journal Title
Journal of International Medical Research
Volume
50
Issue
6
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of International Medical Research Vol.50 No.6 (2022)
Suggested Citation
Jaipanya P., Chanplakorn P. Prolonged durability of extensive contiguous spinal metastasis stabilization in non-small cell lung cancer patients receiving targeted therapy: two case reports and a literature review. Journal of International Medical Research Vol.50 No.6 (2022). doi:10.1177/03000605221105003 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/83718
Title
Prolonged durability of extensive contiguous spinal metastasis stabilization in non-small cell lung cancer patients receiving targeted therapy: two case reports and a literature review
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Contiguous spinal metastasis poses a challenge for spine surgeons. In patients with a short remaining life expectancy, surgery may be discouraged. However, in select cases, surgery may be inevitable to eliminate pain and improve the patient’s quality of life. Additionally, with advancements in systemic cancer therapy, the efficacy and duration of tumor control have improved significantly. Consequently, a patient’s life expectancy may be difficult to estimate with existing prognostic scores. Because patients may achieve prolonged survival, spinal metastasis surgery could greatly benefit a patient’s quality of life. In this report, we present the details of two patients with non-small lung cancer with contiguous spinal metastasis who underwent spinal surgery for their metastatic disease. After surgery and targeted therapy with epidermal growth factor tyrosine kinase inhibitors (EGFR TKI), the patients attained substantial healing of their previously lytic spines and achieved prolonged survival of up to 42 months. With modern systemic therapy for lung cancer, the treatment of spinal metastatic disease can achieve decent outcomes, even in poor surgical candidates. Mini-abstract: In this report, we present two cases of contiguous spinal metastatic disease in non-small cell lung cancer patients who achieved prolonged survival and stable spinal fixation after treatment with EGFR TKIs.